BCG+MMC trial: adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: a randomised phase III trial (ANZUP 1301)

Overview of attention for article published in BMC Cancer, May 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

So far, Altmetric has seen 11 X posts from 10 X users, with an upper bound of 13,325 followers.

protocol for @anzuptrials BCG MMC trial now published http://t.co/scgecbifMZ - BCG available, look for patients

protocol for @anzuptrials BCG MMC trial now published http://t.co/scgecbifMZ - BCG available, look for patients

protocol published online @ANZUPtrials BCG-MMC trial in #bladdercancer http://t.co/ZlbjOEy4IG now recruiting

protocol published online @ANZUPtrials BCG-MMC trial in #bladdercancer http://t.co/ZlbjOEy4IG now recruiting

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 7 additional X posts.